Fredag 1 November | 00:14:55 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

Tid*
2025-11-14 08:00 Kvartalsrapport 2025-Q3
2025-08-22 08:00 Kvartalsrapport 2025-Q2
2025-05-09 08:00 Kvartalsrapport 2025-Q1
2025-04-09 - Årsstämma
2025-03-05 08:00 Bokslutskommuniké 2024
2024-11-15 08:00 Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-08 - Kvartalsrapport 2024-Q1
2024-04-17 - X-dag ordinarie utdelning BAVA 0.00 DKK
2024-04-16 - Årsstämma
2024-03-06 - Bokslutskommuniké 2023
2023-11-16 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-09 - Kvartalsrapport 2023-Q1
2023-03-31 - X-dag ordinarie utdelning BAVA 0.00 DKK
2023-03-30 - Årsstämma
2023-03-02 - Bokslutskommuniké 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-24 - Kvartalsrapport 2022-Q2
2022-05-09 - Kvartalsrapport 2022-Q1
2022-04-06 - X-dag ordinarie utdelning BAVA 0.00 DKK
2022-04-05 - Årsstämma
2022-03-04 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-27 - Kvartalsrapport 2021-Q1
2021-04-21 - X-dag ordinarie utdelning BAVA 0.00 DKK
2021-04-20 - Årsstämma
2021-03-12 - Bokslutskommuniké 2020
2020-11-11 - Kvartalsrapport 2020-Q3
2020-08-26 - Kvartalsrapport 2020-Q2
2020-06-15 - X-dag ordinarie utdelning BAVA 0.00 DKK
2020-06-12 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-11-27 - Extra Bolagsstämma 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-15 - Kvartalsrapport 2019-Q2
2019-04-25 - X-dag ordinarie utdelning BAVA 0.00 DKK
2019-04-24 - Årsstämma
2018-04-18 - X-dag ordinarie utdelning BAVA 0.00 DKK
2018-04-17 - Årsstämma
2017-04-26 - X-dag ordinarie utdelning BAVA 0.00 DKK
2017-04-25 - Årsstämma
2016-04-21 - X-dag ordinarie utdelning BAVA 0.00 DKK
2016-04-20 - Årsstämma
2015-04-24 - X-dag ordinarie utdelning BAVA 0.00 DKK
2015-04-23 - Årsstämma
2014-04-25 - X-dag ordinarie utdelning BAVA 0.00 DKK
2014-04-24 - Årsstämma
2013-04-18 - X-dag ordinarie utdelning BAVA 0.00 DKK
2013-04-17 - Årsstämma
2012-04-17 - X-dag ordinarie utdelning BAVA 0.00 DKK
2012-04-16 - Årsstämma
2011-04-27 - X-dag ordinarie utdelning BAVA 0.00 DKK
2011-04-26 - Årsstämma
2010-04-28 - X-dag ordinarie utdelning BAVA 0.00 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriLäkemedel & Handel
Bavarian Nordic är verksamt inom biokemi. Idag är bolaget specialiserat inom utveckling, produktion och distribution av vaccin mot infektionssjukdomar i samband med cancerbehandling. Utöver huvudverksamheten framställs även vacciner mot allvarliga sjukdomar som ebola och livmoderhalscancer. Störst verksamhet återfinns inom Europa och Nordamerika, med huvudkontoret beläget i Kvistgaard, Danmark.
2024-03-06 07:50:00

COPENHAGEN, Denmark, March 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.

The transactions concern the award of restricted stock units (RSUs) including matching shares to members of the Company’s Executive Management in accordance with a decision today by the Board of Directors to defer 50% of the annual cash bonus related to Executive Management’s performance in 2023 by conversion into RSUs. The RSUs and matching shares will vest in three years from the date of grant, provided that all vesting conditions have been met.

1.Details of the person discharging managerial responsibilities/person closely associated  
a)NamePaul Chaplin
2.Reason for the notification
a)Position/status

 
President and Chief Executive Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Restricted Stock Units


DK0015998017
b)Nature of the transactionGrant
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 108.8826,736
d)Aggregated information
  • Aggregated volume
  • Price
 

26,736
DKK 2,911,142.00
e)Date of the transaction2024-03-06
f)Place of the transactionOutside a trading venue


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameHenrik Juuel
2.Reason for the notification
a)Position/status

 
Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Restricted Stock Units


DK0015998017
b)Nature of the transactionGrant
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 108.8915,073
d)Aggregated information
  • Aggregated volume
  • Price
 

15,073
DKK 1,641,225.00
e)Date of the transaction2024-03-06
f)Place of the transactionOutside a trading venue


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameJean-Christophe May
2.Reason for the notification
a)Position/status

 
Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Restricted Stock Units


DK0015998017
b)Nature of the transactionGrant
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 108.8912,538
d)Aggregated information
  • Aggregated volume
  • Price
 

12,538
DKK 1,365,321.00
e)Date of the transaction2024-03-06
f)Place of the transactionOutside a trading venue


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameLaurence De Moerlooze
2.Reason for the notification
a)Position/status

 
Executive Vice President and Chief Medical Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Restricted Stock Units


DK0015998017
b)Nature of the transactionGrant
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 108.8912,052
d)Aggregated information
  • Aggregated volume
  • Price
 

12,052
DKK 1,312,334.00
e)Date of the transaction2024-03-06
f)Place of the transactionOutside a trading venue


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameAnu Helena Kerns
2.Reason for the notification
a)Position/status

 
Executive Vice President and Chief People Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Restricted Stock Units


DK0015998017
b)Nature of the transactionGrant
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 108.898,893
d)Aggregated information
  • Aggregated volume
  • Price
 

8,893
DKK 968,397.00
e)Date of the transaction2024-03-06
f)Place of the transactionOutside a trading venue


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameRussell Thirsk
2.Reason for the notification
a)Position/status

 
Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Restricted Stock Units


DK0015998017
b)Nature of the transactionGrant
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 108.8811,757
d)Aggregated information
  • Aggregated volume
  • Price
 

11,757
DKK 1,280,125.00
e)Date of the transaction2024-03-06
f)Place of the transactionOutside a trading venue

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 4 / 2024